List of insiders holdings for ARROWHEAD PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Anzalone Christopher Richard Chief Executive Officer | 2024-02-02 17:25:50 | 4,066,774 0 | 4,066,774 | Form 4 |
| GIVEN BRUCE D Chief Operating Officer | 2020-04-29 19:19:47 | 2,838,205 0 | 2,838,205 | Form 4 |
| STEWART R BRUCE Executive Chairman | 2010-03-08 16:34:19 | 872,000 0 | 872,000 | Form 4 |
| Ekchian Leon President | 2005-11-21 15:31:29 | 750,000 0 | 750,000 | Form 4 |
| Kingsley Joseph Theodore III Chief Financial Officer | 2007-04-09 16:45:40 | 600,000 0 | 600,000 | Form 4 |
| Leone Peter Brian VP, Strategic Bus. Initiatives | 2018-10-23 19:59:55 | 564,488 0 | 564,488 | Form 4 |
| Lewis David L. Chief Scientific Officer | 2016-01-04 19:24:56 | 472,500 0 | 472,500 | Form 4 |
| O'Brien Patrick COO and General Counsel | 2024-01-05 19:58:47 | 464,385 0 | 464,385 | Form 4 |
| Myszkowski Kenneth Allen Chief Financial Officer | 2024-03-08 17:54:54 | 400,600 0 | 400,600 | Form 4 |
| KNOTT DAVID M 10% Owner | 2008-02-13 15:43:14 | 357,143 0 | 357,143 | Form 13G |
| PHILLIPS JAMES M JR Secretary | 2004-04-16 16:38:33 | 300,000 0 | 300,000 | Form 4 |
| McDonnel Paul Clayton CFO (former) | 2009-08-24 13:36:31 | 290,000 0 | 290,000 | Form 4 |
| RAHN LEROY T Director | 2010-03-08 16:33:33 | 225,000 0 | 225,000 | Form 4 |
| Hamilton James C Chief Discovery/Trans Medicine | 2024-04-03 18:05:30 | 204,851 0 | 204,851 | Form 4 |
| Li Zhen Snr. VP, Chem and Non-Clin Dev | 2019-01-16 20:24:20 | 201,700 0 | 201,700 | Form 4 |
| SWIFT ARTHUR L CEO, Unidym Unit | 2007-06-28 15:29:27 | 200,000 0 | 200,000 | Form 3 |
| San Martin Javier Chief Medical Officer | 2024-01-08 17:16:14 | 198,497 0 | 198,497 | Form 4 |
| FRYKMAN EDWARD W Director | 2018-01-03 20:06:48 | 148,852 0 | 148,852 | Form 4 |
| GIVEN DOUGLAS B Director | 2024-01-16 18:06:55 | 129,711 0 | 129,711 | Form 4 |
| Oliver Tracie Chief Commercial Officer | 2024-07-03 17:27:36 | 127,107 0 | 127,107 | Form 4 |
| PERRY MICHAEL S Director | 2023-12-19 15:55:01 | 114,754 0 | 114,754 | Form 4 |
| Hassard James Chief Commercial Officer | 2021-06-24 18:44:06 | 105,750 0 | 105,750 | Form 4 |
| STAMBAUGH LARRY G CEO, Insert/Calando | 2007-11-13 16:34:54 | 100,000 0 | 100,000 | Form 3 |
| Ferrari Mauro Director | 2024-01-16 18:06:27 | 60,778 0 | 60,778 | Form 4 |
| COLLIER CHARLES PATRICK Director | 2004-02-11 11:48:31 | 50,000 0 | 50,000 | Form 3 |
| Jacobs Edward Lee Subsidiary CEO | 2007-01-22 17:27:23 | 50,000 0 | 50,000 | Form 3 |
| Waddill William D. Director | 2024-01-16 18:06:38 | 47,870 0 | 47,870 | Form 4 |
| McKenney Charles Director | 2015-03-06 19:48:30 | 42,220 0 | 42,220 | Form 4 |
| Petrovich John George Subsidiary CEO | 2007-01-22 19:12:56 | 40,474 0 | 40,474 | Form 3 |
| Lu Hongbo Director | 2024-11-15 20:34:11 | 30,430 5,650 | 36,080 | Form 5 |
| De Backer Marianne Director | 2023-01-11 20:38:50 | 35,860 0 | 35,860 | Form 4 |
| Vakiener Victoria Director | 2024-05-06 18:04:38 | 30,205 0 | 30,205 | Form 4 |
| Ching Marshall Robert 10% Owner | 2005-06-27 11:21:24 | 28,666 0 | 28,666 | Form 4 |
| OLUKOTUN ADEOYE Y Director | 2023-12-19 15:54:07 | 22,854 0 | 22,854 | Form 4 |
| Bradshaw Curt Chief Scientific Officer | 2020-11-23 17:58:54 | 0 0 | 0 | Form 4 |